EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtOpen Access

Hyperthermic intraperitoneal chemotherapy for women with granulosa cell tumors of the ovary: a systematic review of the literature

Clemens B Tempfer, Wiebke Solass, Askin Dogan, Lukas A Hefler, Marc-André Reymond

Pleura and Peritoneum · 2016

DOI: 10.1515/pp-2016-0002 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pleura and Peritoneum, 2016. Verfasst von Clemens B Tempfer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Ruhr University Bochum, Marienhospital Herne, Hoelkeskampring 40, 44625 Herne, Germany. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Adult and juvenile granulosa cell tumors of the ovary are rare functional sex-cord-stromal ovarian neoplasms characterized by low malignant potential and late relapse. Evidence-based management options for primary and recurrent juvenile (JGCT) and adult (AGCT) granulosa cell tumors are limited and treatment options have not been standardized. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) may be an option to treat these women effectively.

Methods

Systematic literature review using PubMed and the Cochrane Central Register of Controlled Trials.

Results

No reports of HIPEC among women with a first diagnosis of AGCT were identified. We identified 5 reports on the safety and therapeutic efficacy of CRS and HIPEC in 19 patients with recurrent AGCT and one patient with JGCT. The pooled rate of complete cytoreduction was 95 % (18/19) with 16 % (3/19) severe morbidity and no procedure-related mortality. The median time of follow-up was 30 (range, 3 to 72) months, during which 6/19 (31 %) patients experienced a recurrence and two patients (10 %) died of the disease.

Conclusion

CRS and HIPEC are a safe and potentially effective treatment option for selected women with recurrent AGCT limited to the abdomen.

Schlagwörter

Stichwörter der Autor:innen

HIPECadult granulosa cell tumorcytoreductionintraperitoneal chemotherapyovarian neoplasma.

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Ruhr University Bochum, Marienhospital Herne, Hoelkeskampring 40, 44625 Herne, Germany.
  • Department of Pathology, University of Hannover, Hannover, Germany.
  • Department of Obstetrics and Gynecology, Ruhr University Bochum, Marienhospital Herne, Herne, Germany.
  • Department of Obstetrics and Gynecology, Krankenhaus der Barmherzigen Schwestern, Linz, Austria.
  • Department of Surgery, Ruhr University Bochum, Bochum, Germany.

Zitieren

APA

Tempfer, C. B., Solass, W., Dogan, A., Hefler, L. A., & Reymond, M. A. (2016). Hyperthermic intraperitoneal chemotherapy for women with granulosa cell tumors of the ovary: a systematic review of the literature. Pleura and Peritoneum. https://doi.org/10.1515/pp-2016-0002

Vancouver

Tempfer CB, Solass W, Dogan A, Hefler LA, Reymond MA. Hyperthermic intraperitoneal chemotherapy for women with granulosa cell tumors of the ovary: a systematic review of the literature. Pleura and Peritoneum. 2016. doi:10.1515/pp-2016-0002

BibTeX
@article{Tempfer2016,
  author = {Tempfer, Clemens B and Solass, Wiebke and Dogan, Askin and Hefler, Lukas A and Reymond, Marc-André},
  title = {Hyperthermic intraperitoneal chemotherapy for women with granulosa cell tumors of the ovary: a systematic review of the literature},
  journal = {Pleura and Peritoneum},
  year = {2016},
  doi = {10.1515/pp-2016-0002}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche